RGEN — Repligen Corporation
NASDAQ · Healthcare · Medical - Instruments & Supplies
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 177.36 |
| Market cap (USD) | 11,260,904,000 |
| P/E | 204.32 |
| ROE (%) | 2.37 |
| Net profit margin (%) | 6.65 |
| Revenue growth (%) | 16.36 |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Repligen Corporation
Available company fundamentals for RGEN in Medical - Instruments & Supplies. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.